Empyrean Capital Partners, LP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Empyrean Capital Partners, LP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2014$13,062,000
-61.2%
309,821
-64.3%
0.74%
-37.5%
Q3 2014$33,661,000
+34.7%
868,000
+8.5%
1.19%
+35.2%
Q2 2014$24,984,000800,0000.88%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2014
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders